Comparative Immunogenicity of a Genetically Derived and a Plasma Pooled Hepatitis B Vaccine in Normal Adult Volunteers: Immunogénicité du vaccin hépatite B obtenu soit par la technique d’ADN recombinant soit par un pool de plasma : étude chez des volontaires sains adultes

By Nadeem Irfan Bukhari  

Therapie, Vol. 60, Iss. 3, 2005-01 ,pp. : 311-316

Adis International

Access to resources Recommend Favorite

Recombinant Hepatitis B Vaccine: A Review of its Immunogenicity and Protective Efficacy Against Hepatitis B

By Adkins J.C.   Wagstaff A.J.  

BioDrugs, Vol. 10, Iss. 2, 1998-08 ,pp. : 137-158

Adis International

Access to resources Recommend Favorite

Quality Considerations for Recombinant DNA-Derived Biological Therapeutic Products: A Control Perspective on Cytokines

By Mire-Sluis A.   Thorpe R.  

BioDrugs, Vol. 11, Iss. 6, 1999-06 ,pp. : 367-376

Adis International

Access to resources Recommend Favorite

Ensuring the Biologic Safety of Plasma-Derived Therapeutic Proteins: Detection, Inactivation, and Removal of Pathogens

By Cai Kang   Gierman Todd M.   Hotta JoAnn   Stenland Christopher J.   Lee Douglas C.   Pifat Dominique Y.   Petteway Steve R.  

BioDrugs, Vol. 19, Iss. 2, 2005-01 ,pp. : 79-96

Adis International

Access to resources Recommend Favorite

Antibody Responses of Healthy Infants to Concurrent Administration of a Bivalent Haemophilus influenzae Type b-Hepatitis B Vaccine with Diphtheria-Tetanus-Pertussis, Polio and Measles-Mumps-Rubella Vaccines

By West D.J.  

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 413-418

Adis International

Access to resources Recommend Favorite